다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Biodelivery Sciences International (MM) (BDSIW)
Biodelivery Sciences International (MM) (BDSIW) 뉴스

BDSIW

Biodelivery Sciences International (MM) (BDSIW)

Biodelivery Sciences International (MM)

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:BDSIW

1

일자	시간	출처	헤드라인	심볼	기업
2005/11/08	23:44	Business Wire	BDSI Announces Supply Agreement Relating to BEMA(TM) Fentanyl; Agreement with Aveva Drug Delivery Systems a Key Milestone as BDS	NASDAQ:BDSIW	Biodelivery Sciences International (MM)
2005/11/01	21:30	Business Wire	BDSI Prepares For Phase III with BEMA(TM) Fentanyl Following Positive Results of Comparative Pharmacokinetic Study	NASDAQ:BDSIW	Biodelivery Sciences International (MM)
2005/10/06	00:13	Business Wire	BDSI Closes Public Offering of 4.4 Million Shares	NASDAQ:BDSIW	Biodelivery Sciences International (MM)
2005/09/30	21:04	Business Wire	BDSI Prices Public Offering of 4.4 Million Shares	NASDAQ:BDSIW	Biodelivery Sciences International (MM)
2005/09/30	21:00	Business Wire	BDSI Prices Public Offering of 4.4 Million Shares	NASDAQ:BDSIW	Biodelivery Sciences International (MM)
2005/09/17	05:30	Business Wire	BDSI Announces Director Resignations; Donald Ferguson and Alan Pearce Resign So That Company Can Comply with Nasdaq Independence	NASDAQ:BDSIW	Biodelivery Sciences International (MM)
2005/07/20	23:28	Business Wire	BDSI Announces Acceptance of Emezine(R) NDA for Review By FDA	NASDAQ:BDSIW	Biodelivery Sciences International (MM)
2005/07/19	00:03	Business Wire	BDSI Secures $7 Million Financing Commitment For Development of BEMA(TM) Fentanyl; Funding Targeted for Phase III Trials of Canc	NASDAQ:BDSIW	Biodelivery Sciences International (MM)
2005/06/03	20:00	Business Wire	BDSI Secures Additional $2.5 Million Financing With Laurus Master Fund	NASDAQ:BDSIW	Biodelivery Sciences International (MM)
2005/05/02	20:30	Business Wire	BDSI Announces Submission of NDA for Emezine; First Transmucosal Product for the Treatment of Nausea and Vomiting	NASDAQ:BDSIW	Biodelivery Sciences International (MM)
2004/11/13	06:37	PR Newswire (US)	BDSI Reports Financial Results for the Third Quarter Ended September 30, 2004	NASDAQ:BDSIW	Biodelivery Sciences International (MM)
2004/04/14	01:00	PR Newswire (US)	BioDelivery Sciences International, Inc. Announces Licensing of Its Topical BioNasal (TM) Amphotericin B for Chronic Sinusitis	NASDAQ:BDSIW
2004/04/06	21:00	PR Newswire (US)	BioDelivery Sciences International, Inc. Reports 2003 Results	NASDAQ:BDSIW	Biodelivery Sciences International (MM)

검색 관련기사 보기:NASDAQ:BDSIW

1

Health Care Select Sector

Deutsche Telekom (QX)

Invesco QQQ Trust Series 1

US Dollar vs Sterling

US Dollar vs Yen

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관